Download FREE Report Sample
Download Free sampleQuetiapine, used in various types of schizophrenia, not only schizophrenia positive symptoms effective, negative symptoms have a certain effect.It can also reduce the emotional symptoms associated with schizophrenia such as depression, anxiety and cognitive deficits.
Quetiapine Market contains market size and forecasts of Quetiapine in global, including the following market information:
Global Quetiapine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Quetiapine Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Quetiapine companies in 2021 (%)
The global Quetiapine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immediate Release Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Quetiapine include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical and Hunan Dongting Pharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Quetiapine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Quetiapine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Quetiapine Market Segment Percentages, by Type, 2021 (%)
Immediate Release Tablets
Extended Release Tablets
Global Quetiapine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Quetiapine Market Segment Percentages, by Application, 2021 (%)
Adult
Old Man
Children And Adolescents
Global Quetiapine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Quetiapine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Quetiapine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Quetiapine revenues share in global market, 2021 (%)
Key companies Quetiapine sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Quetiapine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Hunan Dongting Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
